Advanced Search

Pediatric Coding Alert

Reader Question:

Preauthorizing Synagis

Published on Fri Mar 01, 2002

Question: How can I streamline the process of preauthorizing Synagis?

Texas Subscriber  
Answer: Synagis (CPT 90378 , Respiratory syncytial virus immune globulin [RSV-IgIM], for intramuscular use, 50 mg, each) costs $1,000 a month and must be taken for six months. Although the drug is expensive, insurance companies will pay for it because it reduces hospitalizations. But they require preauthorization, and the time spent obtaining this is not billable. To cut down on the work involved, obtain the preauthorization in writing, rather than over the telephone.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pediatric Coding Alert

View All